about
Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstructionApoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaRedesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.Medical treatment of benign prostatic hyperplasia.Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safetyAndrogens and estrogens in benign prostatic hyperplasia: past, present and future.Towards the prevention and management of prostatic diseases in Nigeria: a framework.Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.itBenign prostatic hyperplasia. Part 2--management.Alpha1-adrenoceptor subtypes and lower urinary tract symptomsSingapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.Diagnosis and management of benign prostatic hyperplasia in primary care.Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells.
P2860
Q24186736-63150ACB-30F8-49C0-AF40-46A631CF11C5Q24188312-B6480397-7067-45E8-BAE2-59D9EB90F2EDQ26741226-017F5DED-2F70-4C21-92ED-AB01DF094396Q30432603-063D39D2-D46A-46BE-9AA5-B43C7B0EA86BQ33588534-39E4C682-22BC-4D65-9A04-9D0DEBB2FE00Q33769561-DBCDCF01-D5A3-4764-AD7E-36C23B2AF848Q35101633-0A1453E3-BF3B-4D84-8BA4-5F16EE8043FAQ35231660-83FB4BFA-3BFD-4CC4-B539-CE5B067BABDEQ35550448-04896E1F-15D0-445E-B1B4-6B5EC0FEA335Q36379355-A8ED8D24-0F18-4294-8B29-8087D616704CQ36405351-C26F5414-2775-4C2E-AF74-0E5F24FCA12FQ36579735-877A2425-2EC8-45DA-BC27-260F03370724Q40067041-79E96DDC-84BD-44AB-9D02-AC018BD7FF0EQ41484907-229F6C67-4512-4C20-870E-A05FFDE5695CQ41986288-AC0C1F2C-1CC2-4097-9358-F34C517272D6Q43892537-AD378566-B989-4BC5-9F74-44F2081E181A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pygeum africanum for benign prostatic hyperplasia.
@ast
Pygeum africanum for benign prostatic hyperplasia.
@en
type
label
Pygeum africanum for benign prostatic hyperplasia.
@ast
Pygeum africanum for benign prostatic hyperplasia.
@en
prefLabel
Pygeum africanum for benign prostatic hyperplasia.
@ast
Pygeum africanum for benign prostatic hyperplasia.
@en
P2093
P2860
P1476
Pygeum africanum for benign prostatic hyperplasia.
@en
P2093
P2860
P304
P356
10.1002/14651858.CD001044
P577
2002-01-01T00:00:00Z